If a surgical staple gun malfunctioned so seriously that it generated not a few dozen formal complaints but more than 10,000 reported incidents, shouldn’t patients, doctors, and hospitals have the right to know that information from the federal agency overseeing the safety of medical devices? Apparently not. Or maybe not without a big kick in….
Continue ReadingArchives for March 2019
For diabetics and dialysis patients, glimmers of better news on costs of care
Diabetics and those with failing kidneys may have gotten a glimmer of relief from the staggering costs of caring for their conditions, as Big Pharma relented a tad with news it will put out a less-costly insulin product and federal officials suggesting Uncle Sam soon may be upsetting the flush profits of the dialysis industry.
Continue ReadingFor diabetics and dialysis patients, glimmers of better news on costs of care
Diabetics and those with failing kidneys may have gotten a glimmer of relief from the staggering costs of caring for their conditions, as Big Pharma relented a tad with news it will put out a less-costly insulin product and federal officials suggesting Uncle Sam soon may be upsetting the flush profits of the dialysis industry…..
Continue ReadingWith FDA chief gone, doubts rise on battles on nicotine, opioids, drug costs
The Trump Administration has lost yet another top health official: So, what happens now with key policies pushed by Scott Gottlieb, the departing federal Food and Drug Administration commissioner, to battle teen nicotine abuse, cut skyrocketing drug costs, and attack the opioid crisis? Administration officials insist Gottlieb wasn’t ousted, and the physician and onetime Big
Continue ReadingWith FDA chief gone, doubts rise on battles on nicotine, opioids, drug costs
The Trump Administration has lost yet another top health official: So, what happens now with key policies pushed by Scott Gottlieb, the departing federal Food and Drug Administration commissioner, to battle teen nicotine abuse, cut skyrocketing drug costs, and attack the opioid crisis? Administration officials insist Gottlieb wasn’t ousted, and the physician and onetime Big….
Continue ReadingCatching up on your sleep this weekend? It doesn’t work, researchers find
Americans may put off to the weekend catching up on sports scores, store sales, the latest news and more. But there’s a health essential that new research suggests cannot be put off for the weekend: a good night’s sleep. The study, conducted at the University of Colorado and published in the science journal “Current Biology,”….
Continue ReadingCatching up on your sleep this weekend? It doesn’t work, researchers find
Americans may put off to the weekend catching up on sports scores, store sales, the latest news and more. But there’s a health essential that new research suggests cannot be put off for the weekend: a good night’s sleep. The study, conducted at the University of Colorado and published in the science journal “Current Biology,” focused….
Continue ReadingIf a news reporter can get named a ‘Top Doctor,’ how do patients find reliable info on good MDs?
Truth can be stranger than fiction, and for an investigative journalist covering the outrages of health care costs, ProPublica reporter Marshall Allen had a dream medical story call him on his phone: A well-known New York company reached out and told him he had been “honored” as one of the nation’s Top Doctors. Not bad
Continue ReadingIf a news reporter can get named a ‘Top Doctor,’ how do patients find reliable info on good MDs?
Truth can be stranger than fiction, and for an investigative journalist covering the outrages of health care costs, ProPublica reporter Marshall Allen had a dream medical story call him on his phone: A well-known New York company reached out and told him he had been “honored” as one of the nation’s Top Doctors. Not bad….
Continue ReadingFor soaring drug costs and overdoses, officials offer blame and shame
As tens of thousands of Americans die from overdoses and many millions struggle with skyrocketing prescription medication costs, lawmakers and regulators in the nation’s capital plodded along with procedural steps they claimed would help attack what voters insist are some of their top public policy priorities. On Capitol Hill, seven of Big Pharma’s top executives….
Continue Reading